Genetic testing of BRCA1-and BRCA2-associated hereditary breast and ovarian cancer at the University of Debrecen

被引：0

作者：

Madar, Laszlo ^{[1
]}

Majoros, Viktoria ^{[1
]}

Nagy, Orsolya ^{[1
]}

Szucs, Zsuzsanna ^{[1
]}

Csorba, Gabriella ^{[1
]}

Bako, Andrea ^{[2
]}

Bajusz, Eva Fiakne ^{[2
]}

Toth, Judit ^{[2
]}

Budi, Laszlo ^{[3
,4
]}

Krasznai, Zoard Tibor ^{[5
]}

Balogh, Istvan ^{[1
,6
]}

Koczok, Katalin ^{[1
]}

机构：

[1] Univ Debrecen, Div Clin Genet, Dept Lab Med, Fac Med, Debrecen, Hungary

[2] Univ Debrecen, Dept Oncol, Ctr Clin, Debrecen, Hungary

[3] Borsod Abauj Zemplen Cty Cent Hosp, Miskolc, Hungary

[4] Univ Teaching Hosp, Dept Oncol, Clin Oncol & Radiat Therapy Ctr, Miskolc, Hungary

[5] Univ Debrecen, Fac Med, Dept Gynecol & Obstet, Debrecen, Hungary

[6] Univ Debrecen, Dept Human Genet, Fac Med, Debrecen, Hungary

来源：

EUROPEAN JOURNAL OF HUMAN GENETICS | 2024年 / 32卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

P13.036.D

引用

页码：556 / 556

页数：1

共 50 条

[1] Clinical management of BRCA1-and BRCA2-associated breast cancer
Karp, SE
SEMINARS IN SURGICAL ONCOLOGY, 2000, 18 (04): : 296 - 304
[2] Molecular and Histopathologic Correlation of BRCA1-and BRCA2-Associated Invasive Breast Carcinoma
Shao, Tiffany
Lerner-Ellis, Jordan
Chang, Martin C.
LABORATORY INVESTIGATION, 2016, 96 : 72A - 72A
[3] Molecular and Histopathologic Correlation of BRCA1-and BRCA2-Associated Invasive Breast Carcinoma
Shao, Tiffany
Lerner-Ellis, Jordan
Chang, Martin C.
MODERN PATHOLOGY, 2016, 29 : 72A - 72A
[4] Toxicity of (neo)adjuvant chemotherapy in BRCA1-and BRCA2-associated versus sporadic breast cancer patients
Drooger, J.
Heemskerk-Gerritsen, B.
Smalllenbroek, N.
Epskamp, C.
Seynaeve, C.
Jager, A.
EUROPEAN JOURNAL OF CANCER, 2016, 57 : S101 - S101
[5] Pathology of BRCA1-and BRCA2-associated breast cancers: known and less known connections
Fostira, F.
Fountzila, E.
Vagena, A.
Apostolou, P.
Konstanta, I.
Papadimitriou, C.
Razis, E.
Christodoulou, C.
Timotheadou, E.
Mollaki, V.
Papamentzelopoulou, M.
Vlachos, I. S.
Yannoukakos, D.
Konstantopoulou, I.
ANNALS OF ONCOLOGY, 2016, 27
[6] Improved outcome after first line chemotherapy in BRCA1-and BRCA2-associated ovarian cancer compared with sporadic ovarian cancer patients
Seynaeve, C.
Hoogwerf, D.
Kriege, M.
Beugelink, S.
Jager, A.
Collee, J.
Berns, E. M.
van der Burg, M. E. L.
Burger, C. W.
Vencken, P.
EJC SUPPLEMENTS, 2009, 7 (02): : 452 - 452
[7] BRCA1 - Genetic testing and hereditary breast and ovarian cancer
Ross, DW
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1997, 121 (07) : 754 - 755
[8] Histopathology of BRCA1- and BRCA2-associated breast cancer
Honrado, Emiliano
Benitez, Javier
Palacios, Jose
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (01) : 27 - 39
[9] Familial non-BRCA1/BRCA2-associated breast cancer
Eccles, DM
Pichert, G
LANCET ONCOLOGY, 2005, 6 (09): : 705 - 711
[10] Are BRCA1- and BRCA2-associated breast cancers different?: Prognosis of BRCA1-associated breast cancer
Robson, M
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 113S - 118S

← 1 2 3 4 5 →